Precision Medicine and the Fate of Federal Dollars – A Prediction
Majid Ali, M.D.
In January 2015, President Barak Obama in his State of the Union Message proposed a new initiative of developing personalized medicine. For his budget expected to follow the speech, he sought hundreds of millions of dollars. It is safe to predict that these amounts will blow up to billion of dollars.
What will be the fate of these federal dollars? Here is my prediction: Some rich corporate will be further enriched. They will undoubtedly throw some crumbs to the doctors in their keep. People with chronic disorders—diabetes, hypertension, asthma, heart disease, environmental illnesses, childrens’ developmental problems (ADHD, autism spectrum, and others), nutritional deficiencies, heavy metal toxicities, and immune disease—will not receive any benefits from the promise of personalized medicine.
The rich will move on to newer arenas of lobbying and newer shapes of deception. A gray-haired President Obama will be too depleted to worry about the fate of his promised personalized medicine.
I base my predictions on the following:
* There is no evidence that money spent on DNA research in the past decades has done anything good for sufferers of diseases mentioned above.
* Federal dollars will bring very limited benefits to a small number of people with acute illness.
I point out that the language of genes is far too complex and far too many of them are involved in the cause of above-mentioned diseases to lend themselves to simple-minded presidential notions of Star Wars medicine.
One other important point should be recognized in this context: Acute illnesses rarely represent sudden departures from health.